C105P: Evolocumab Biosimilar, PCSK9 Monoclonal Antibody
Recombinant fully human IgG2 monoclonal antibody.
Specificity/Sensitivity: The monoclonal antibody evolocumab biosimilar specifically binds to the human PCSK9.
Applications: ELISA, flow cytometry, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by evolocumab.BP001728-CA83: Recombinant Human Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Protein
Source: HEK 293-derived.
Purity: >95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).BP001728-CA87: Recombinant Human Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Protein
Source: HEK 293-derived.
Purity: >95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).